960234-41-7 Usage
Uses
Used in Pharmaceutical Synthesis:
2-(cyclopropylthio)-5-nitrobenzaldehyde is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic effects. Its unique structure and reactivity allow for the creation of diverse molecular entities with specific biological activities.
Used in Agrochemical Production:
In the agrochemical industry, 2-(cyclopropylthio)-5-nitrobenzaldehyde serves as an intermediate in the synthesis of various agrochemicals, including pesticides and herbicides. Its chemical properties enable the production of effective compounds designed to protect crops and enhance agricultural productivity.
Used in Medicinal Chemistry Research:
2-(cyclopropylthio)-5-nitrobenzaldehyde is utilized in medicinal chemistry research as a key building block for the design and synthesis of novel bioactive molecules. Its structural features and reactivity facilitate the exploration of new chemical space and the discovery of potential drug candidates.
Used in Materials Science:
In materials science, 2-(cyclopropylthio)-5-nitrobenzaldehyde has potential applications in the development of new materials with specific properties. Its versatility in chemical reactions allows for the creation of materials with tailored characteristics for use in various industries, such as electronics, coatings, and adhesives.
Check Digit Verification of cas no
The CAS Registry Mumber 960234-41-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,6,0,2,3 and 4 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 960234-41:
(8*9)+(7*6)+(6*0)+(5*2)+(4*3)+(3*4)+(2*4)+(1*1)=157
157 % 10 = 7
So 960234-41-7 is a valid CAS Registry Number.
960234-41-7Relevant academic research and scientific papers
BENZAMIDE FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS
-
Page/Page column 61, (2010/09/17)
The present invention provides novel benzamide derivatives of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables A, W, Y, Z, R8, and R9 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.
MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS
-
Page/Page column 99, (2008/12/07)
The present invention relates generally to novel macrocycles of Formula (I) or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein the variables A, B, C, D, L, M, W, Z1, Z2, Z3, Z4, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.
BICYCLIC LACTAM FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS
-
Page/Page column 139-140, (2008/12/07)
The present invention provides novel bicyclic lactams derivatives, and analogues thereof, of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables A, B, C, W, Y, Z1, Z2, Z3, Z4, R8, and R9 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.
